Mechanistically, CCDC65 induced by metformin suppresses the cell growth and metastasis of GC, acting through the repression of AKT1 signaling pathway via promoting FBXW7-mediated ubiquitination and degradation of ENO1. The gene discussed is AKT1; the disease is gastric cancer.